简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-05-19 19:48 Exscientia to Report First Quarter 2022 Financial Results on May 25, 2022
2022-05-19 14:17 New Milestone Clinical Study Shows Postbiotic Urolithin A (Mitopure™) Improves Muscle Strength and Exercise Performance in Middle Aged Adults
2022-05-19 10:21 Xlear Teams Up With Dr. Ferrer BioPharma to Bring a Better User Experience to Nasal Hygiene
2022-05-18 12:55 Innovative AI software for the detection of pancreatic diseases: first-in-human application successful
2022-05-18 11:24 University of Nebraska Medical Center and ANANDA Scientific announce FDA approval of the IND for a Clinical Trial exploring Treatment for Post-Traumatic Stress Disorder (PTSD)
2022-05-17 18:34 KAUST Spins-in Five Cutting-Edge International Startups and Brings New Tech to Saudi Arabia
2022-05-16 09:48 PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients
2022-05-16 09:39 Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
2022-05-16 09:36 Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
2022-05-13 09:39 Update on the timeline for Vifor Pharma tender offer
2022-05-11 16:34 Mawi DNA Technologies Launches NextSWAB™ For Accurate, More Reliable COVID-19 Test Results
2022-05-09 10:08 CureApp: World’s First Medical Device Regulatory Approval of Digital Therapeutic App for Hypertension
2022-05-09 09:28 New England Biolabs Continues Microbial Fermentation Partnership with ABEC
2022-05-06 09:23 Rhizen Pharmaceuticals AG Announces Promising Interim Data Presentation From an Ongoing Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients At ESMO Breast Cancer Meeting 2022
2022-05-06 08:16 Covetrus Introduces Innovative Cloud-Based Practice Management Software for Veterinarians in the United Kingdom, EMEA and Asia Pacific
2022-05-05 14:15 AleAlentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officercer
2022-05-05 13:29 Groundbreaking research cooperation: The Medi-Globe Group and the IHU in Strasbourg are developing the world's first AI software for detecting pancreatic diseases
2022-05-05 08:35 Patient Safety Movement Foundation Announces Winners of 2021 Humanitarian and Lewis Blackman Awards
2022-05-04 21:55 Exscientia to Present at the BofA Securities 2022 Healthcare Conference
2022-05-04 21:49 Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma